Sex differences in cerebral energy metabolism in Parkinson's disease: A phosphorus magnetic resonance spectroscopic imaging study

Parkinsonism and Related Disorders

Volumn 20, Issue 5, 2014, Pages 545-548

  Weiduschat, Nora ^a   Mao, Xiangling ^a   Beal, M Flint ^a   Nirenberg, Melissa J ^b   Shungu, Dikoma C ^a   Henchcliffe, Claire ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Biomarker; Magnetic resonance spectroscopy; Mitochondrial dysfunction; Oxidative stress; Parkinson's disease; Sex differences

Indexed keywords

ADENOSINE TRIPHOSPHATE; CREATINE PHOSPHATE; DOPAMINE RECEPTOR STIMULATING AGENT; LEVODOPA; MONOAMINE OXIDASE INHIBITOR; PHOSPHATE; PHOSPHORUS;

ADULT; ARTICLE; BRAIN LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; CROSS-SECTIONAL STUDY; DISEASE DURATION; ENERGY METABOLISM; FEMALE; GRAY MATTER; HEMISPHERE; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; ONSET AGE; PARKINSON DISEASE; PHOSPHORUS MAGNETIC RESONANCE SPECTROSCOPIC IMAGING; PRIORITY JOURNAL; SEX DIFFERENCE; TEMPOROPARIETAL CORTICAL GRAY MATTER; UNIFIED PARKINSON DISEASE RATING SCALE; AGED; CASE CONTROL STUDY; DIAGNOSTIC USE; METABOLISM; MIDDLE AGED; NONPARAMETRIC TEST; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PARIETAL LOBE; PATHOLOGY; PHYSIOLOGY; PROCEDURES; SEXUAL DEVELOPMENT;

ADENOSINE TRIPHOSPHATE; ADULT; AGED; CASE-CONTROL STUDIES; CORPUS STRIATUM; ENERGY METABOLISM; FEMALE; GRAY MATTER; HUMANS; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; PARIETAL LOBE; PARKINSON DISEASE; PHOSPHORUS; SEX CHARACTERISTICS; STATISTICS, NONPARAMETRIC;

EID: 84900016153     PISSN: 13538020     EISSN: 18735126     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2014.02.003     Document Type: Article

References (14)

1. Henchcliffe C., Beal M. Mitochondrial biology and oxidative stress in Parkinson disease pathogenesis. Nat Clin Pract Neurol 2008, 4(11):600-609.
2. Hattingen E., Magerkurth J., Pilatus U., Mozer A., Seifried C., Steinmetz H., et al. Phosphorus and proton magnetic resonance spectroscopy demonstrates mitochondrial dysfunction in early and advanced Parkinson's disease. Brain 2009, 132(Pt 12):3285-3297.
3. Hu M., Taylor-Robinson S., Chaudhuri K., Bell J., Labbé C., Cunningham V., et al. Cortical dysfunction in non-demented Parkinson's disease patients: a combined (31)P-MRS and (18)FDG-PET study. Brain 2000, 123(Pt 2):340-352.
4. Barbiroli B., Martinelli P., Patuelli A., Lodi R., Iotti S., Cortelli P., et al. Phosphorus magnetic resonance spectroscopy in multiple system atrophy and Parkinson's disease. Mov Disord 1999, 14(3):430-435.
5. Rango M., Bonifati C., Bresolin N. Parkinson's disease and brain mitochondrial dysfunction: a functional phosphorus magnetic resonance spectroscopy study. JCereb Blood Flow Metab 2006, 26(2):283-290.
6. Fahn S., Elton R. Unified Parkinson's disease rating scale. Recent developments in Parkinson's disease 1987, 153-163. UPDRS Program Members, Macmillan Healthcare Information, Florham Park, NJ. S. Fahn, C. Marsden, M. Goldstein, D. Calne (Eds.).
7. Weiduschat N., Mao X., Beal M.F., Nirenberg M.J., Shungu D.C., Henchcliffe C. Usefulness of proton and phosphorus MR spectroscopic imaging for early diagnosis of Parkinson's disease. JNeuroimaging 2013; Dec 10, [Epub ahead of print]. 10.1111/jon.12074.
8. Shungu D.C., Weiduschat N., Murrough J., Mao X., Pillemer S., Dyke J.P., et al. Increased ventricular lactate in chronic fatigue syndrome. III: relationship to cortical glutathione and clinical symptoms implicate oxidative stress in disorder pathophysiology. NMR Biomed 2012, 25(9):1073-1087.
9. Pavon J.M., Whitson H.E., Okun M.S. Parkinson's disease in women: a call for improved clinical studies and for comparative effectiveness research. Maturitas 2010, 65(4):352-358.
10. Shen C., Guo Y., Luo W., Lin C., Ding M. Serum urate and the risk of Parkinson'sdisease: results from a meta-analysis. Can J Neurol Sci 2013, 40(1):73-79.
11. Nilsen J., Diaz Brinton R. Mechanism of estrogen-mediated neuroprotection: regulation of mitochondrial calcium and Bcl-2 expression. Proc Natl Acad Sci U S A 2003, 100(5):2842-2847.
12. Gillies G.E., McArthur S. Estrogen actions in the brain and the basis for differential action in men and women: a case for sex-specific medicines. Pharmacol Rev 2010, 62(2):155-198.
13. Cereda E., Baricehlla M., Cassani E., Caccialanza R., Pezzoli G. Reproductive factors and clinical features of Parkinson's disease. Parkinsonism Relat Disord 2013, 19(12):1094-1099.
14. Forester B.P., Berlow Y.A., Harper D.G., Jensen J.E., Lange N., Froimowitz M.P., et al. Age-related changes in bioenergetics and phospholipid metabolism. NMR Biomed 2010, 23(3):242-250.